Triple
T2190768
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Janssen COVID-19 Vaccine |
E49854
|
entity |
| Predicate | efficacyAgainstSymptomaticCOVID19 |
P37231
|
FINISHED |
| Object | approximately 66 percent in global phase 3 trial |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: approximately 66 percent in global phase 3 trial | Statement: [Janssen COVID-19 Vaccine, efficacyAgainstSymptomaticCOVID19, approximately 66 percent in global phase 3 trial]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: efficacyAgainstSymptomaticCOVID19 Context triple: [Janssen COVID-19 Vaccine, efficacyAgainstSymptomaticCOVID19, approximately 66 percent in global phase 3 trial]
-
A.
covid19Impact
Indicates the effect, consequences, or influence that COVID-19 has on a given entity, condition, or situation.
-
B.
covid19VaccineType
Indicates the specific type or category of COVID-19 vaccine associated with an entity.
-
C.
hasTargetDisease
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
-
D.
vaccineUsed
Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
-
E.
typeOfRemedy
Indicates that one entity is a specific kind or category of remedy in relation to another entity.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
| PDg | Predicate description generation | batch_69abbf9c77fc8190a323bcaf644fb2c5 |
completed | March 7, 2026, 6:03 a.m. |
Created at: March 4, 2026, 7:46 p.m.